Paracervical block with ropivacaine for pain relief in second trimester medical abortion - a double blind placebo controlled randomized trial

Status

Not yet recruiting

Phases

Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-524599-52-03

Enrollment

132

Registered

2026-07-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abortion

Brief summary

Primary outcome is maximum pain score on a VAS (measured in millimeters) during the procedure

Interventions

DRUGROPIVACAINE

DRUGELECTROLYTES

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Primary outcome is maximum pain score on a VAS (measured in millimeters) during the procedure	—

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 18, 2026